Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Cell>Point LLC develops intra-nuclear universal molecular imaging and therapeutic products for the diagnosis, staging, treatment and post therapy assessment of cancer, cardiovascular diseases, and infectious diseases. It focuses on chelation based metabolic imaging and intra-nuclear target specific therapy for oncology, cardiology including stroke, diabetes, neuroendocrine, and ischemic based diseases. The company was founded by Greg Russel Colip, Terry Allen Colip and Jerry Bryant in 2001 and is headquartered in Centennial, CO.

Borealis is a leading provider of innovative solutions in the fields of polyolefins, base chemicals and fertilizers. With head office in Vienna, Austria, Borealis currently employs around 6,800 people and operates in over 120 countries. It generated EUR 8.3 billion in sales revenue and a net profit of EUR 906 million in 2018. Mubadala, through its holding company, owns 64% of the company, with the remaining 36% belonging to OMV, an international, integrated oil and gas company based in Vienna. Borealis provides services and products to customers around the world in collaboration with Borouge, a joint venture with the Abu Dhabi National Oil Company (ADNOC).

Joint Analytical Systems GmbH is a German private company located in Moers. The firm engages in analytical instruments services. It was founded in 1995. Joachim Gerstel and Bekim Borovci are the current co-CEOs of the firm.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Nippon Kayaku produces and retails a range of chemicals. By product category, the company divides itself into four areas. Epoxy resins used as flame retardants in electronics, colorants, and dyes used in inkjet printers and materials for the production of textiles are sold by the functional chemicals segment, which is the one that generates the most income of any segment. Pharmaceutical companies market anti-cancer, biological, cardiovascular, vitamin, and anti-inflammatory medications. The automotive sector is supplied by the safety systems segment with airbag inflators and micro gas generators for seatbelt pre-tensioners, both of which are intended to protect passengers in the event of an accident. Insecticides and herbicides are offered for sale in the agrochemicals market.

Taro Pharmaceuticals U.S.A., Inc., a subsidiary of Sun Pharmaceutical Industries Ltd., is an American company located in Hawthorne, NY. The firm manufactures and sells generic pharmaceutical products.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

Guangdong Luofushan Sinopharm Co., Ltd., established on 2008-12-24, Business scope includes pharmaceutical production,Pharmaceutical business;Chinese herbal medicine acquisition;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Production and sales of disinfection products;Food production and sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of daily chemical products;Cosmetics Wholesale;Investment in pharmaceutical and other industries,Management and related consulting services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shijiazhuang Ruikai Chemical Co., Ltd., established on 2007-02-28, The scope of business includes chlorfenapyr,Nitenpyram,pyraclostrobin,Glufosinate-ammonium50%,Lufenuron,Fenflux,Glufosinate-ammonium95%,Pymetrozine,Thiamethoxam,Thiabendazole,Spirofen,pyriproxyfen,lambda-cyhalothrin,Ethephon,Chlorpyrifos,Chlorothalonil,Bensulfuron-methyl,Production of bispyribac(Only produced according to the varieties approved by the pesticide registration certificate);Sales of pesticides produced by the enterprise;2-chlorine-5Chloromethylthiazole,Glufosinate-ammonium,Production of iminodiazines,Sales;The company produces,Raw and auxiliary materials required for scientific research,Instrumentation,Equipment(Except for special equipment),Machinery Parts,industrial salt,Chemical materials(Hazardous chemicals and precursor drugs are excluded)Sales;Organic Fertilizer Production,processing,Sales;Production of Water Soluble Fertilizers,Sales(branch only);Fine Chemicals(Does not contain:Hazardous chemicals and other pre-administrative licensing items)technology development,technical consulting,Technical Services;Unrestricted Pesticide Sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(All of the above laws,Matters prohibited or restricted by regulations and decisions of the State Council shall not be operated;Matters requiring approval from other departments,after approval,before operating)**

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG is a German private company located in Schoenefeld. The firm provides professional, scientific and technical services. It was founded in 2007.

NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON.

Part of NIPPON STEEL CORP., Nippon Steel Co., Ltd. is a Japanese company located in Kishiwada-shi. The firm manufactures steel products. It was acquired by OSAKA STEEL CO., LTD. on January 21, 2005 for $4.25 million.

Biophore is a developer and manufacturer of pharmaceutical products for the generic industry.

Nippon Steel & Sumikin Materials Co., Ltd., a subsidiary of Nippon Steel Corp. /New/, is a Japanese company located in Tokyo that manufactures and wholesales stainless steel foil products.

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.